Prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy and influencing factors

Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society
Elif AtagAziz Karaoglu

Abstract

Depression is one of the most prevalent causes of distress in the geriatric population. The purpose of this study was to examine the prevalence of depressive symptoms in elderly cancer patients and to determine the possible associated factors. Cancer patients 65 years or older and on active chemotherapy completed the Yesavage Geriatric Depression Scale. We examined the relationship of depressive symptoms with age, gender, marital status, educational background, type of cancer, stage of disease, comorbidities, types of treatment for cancer, the duration after diagnosis of cancer, social support, and pain status. The study included 170 patients with a mean age of 71 years, and 47.1% were women. The prevalence of a high depressive symptom score was 19.4%. Of the patients who had a high depressive symptom score based on the Yesavage Geriatric Depression Scale, 18.2% had already been diagnosed with depression and used antidepressants. The mean pain score was significantly higher in patients who had a high depressive symptom score compared to others (P = 0.012). The prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy was similar to that in the geriatric population without cancer. It was also consistent...Continue Reading

References

Apr 1, 1990·Journal of the American Geriatrics Society·B A FerrellD Osterweil
Mar 1, 1987·The Medical Clinics of North America·M J Massie, J C Holland
Jan 1, 1982·Journal of Psychiatric Research·J A YesavageV O Leirer
Apr 1, 1980·The American Journal of Psychiatry·D Blazer, C D Williams
May 28, 1997·JAMA : the Journal of the American Medical Association·J UnützerW Katon
Oct 26, 1999·The British Journal of Psychiatry : the Journal of Mental Science·A T BeekmanM J Prince
May 8, 2000·Journal of the American Geriatrics Society·S Liao, B A Ferrell
Jan 7, 2003·Drugs & Aging·Mellar P Davis, Manish Srivastava
Apr 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L RepettoM Pietropaolo
Nov 11, 2003·Critical Reviews in Oncology/hematology·Andrew J Roth, Reena Modi
Jan 14, 2004·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·John E Morley
May 4, 2004·The American Journal of Psychiatry·Kenneth M LangaSandeep Vijan
Jul 21, 2004·Journal of the National Cancer Institute. Monographs·Arati Rao, Harvey Jay Cohen
Nov 18, 2004·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Manfred StommelBarbara A Given
Dec 14, 2007·Journal of Psychosocial Oncology·Derek R HopkoChristine Mullane
Jun 19, 2008·Journal of Affective Disorders·Mari Lloyd-WilliamsMick Dennis
Jan 16, 2009·The Oncologist·Mark I WeinbergerChristian J Nelson
Dec 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian J NelsonAndrew J Roth
Dec 18, 2009·Surgical Oncology·Carlo CaltagironeGianfranco Spalletta
Aug 8, 2014·Psycho-oncology·Talia R Weiss WieselUNKNOWN Cancer Aging Research Group (CARG)
Oct 1, 2014·Archives of Gerontology and Geriatrics·Efi ParpaKyriaki Mystakidou
May 20, 2016·Psycho-oncology·Rebecca M SaracinoChristian J Nelson

❮ Previous
Next ❯

Citations

Jun 18, 2021·Aging & Mental Health·Tom BorzaMarit Slaaen
Jul 3, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Baran AkagunduzYusuf Arslan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.